Repligen Corporation

RGEN · Moat type: UNBESTIMMT

MoatScore

2/10

Fair Value

32 USD

Margin of Safety

-354.0 %

Rating

MEIDEN

GESCHÄFTSMODELL Repligen Corporation develops and distributes bioprocess technologies – in particular filtration systems, chromatography components, and process analytics – which are predominantly used as consumables and single-use systems in biopharmaceutical production and thus exhibit a semi-cyclical model with a significant consumables component.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.